Joseph Jaffe

770 total citations
17 papers, 622 citations indexed

About

Joseph Jaffe is a scholar working on Public Health, Environmental and Occupational Health, Infectious Diseases and Epidemiology. According to data from OpenAlex, Joseph Jaffe has authored 17 papers receiving a total of 622 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Public Health, Environmental and Occupational Health, 7 papers in Infectious Diseases and 6 papers in Epidemiology. Recurrent topics in Joseph Jaffe's work include Streptococcal Infections and Treatments (9 papers), Neonatal and Maternal Infections (7 papers) and Antimicrobial Resistance in Staphylococcus (7 papers). Joseph Jaffe is often cited by papers focused on Streptococcal Infections and Treatments (9 papers), Neonatal and Maternal Infections (7 papers) and Antimicrobial Resistance in Staphylococcus (7 papers). Joseph Jaffe collaborates with scholars based in Israel and United States. Joseph Jaffe's co-authors include Emanuel Hanski, Allon E. Moses, Mary Dan‐Goor, Miriam Ravins, Carlos Hidalgo‐Grass, Shira Natanson‐Yaron, Michael G. Caparon, Lea Valinsky, Colin Block and Ran Nir‐Paz and has published in prestigious journals such as The Lancet, Journal of Clinical Microbiology and The Journal of Infectious Diseases.

In The Last Decade

Joseph Jaffe

16 papers receiving 611 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joseph Jaffe Israel 11 447 395 107 83 81 17 622
Nicola Horstmann United States 15 531 1.2× 382 1.0× 207 1.9× 220 2.7× 76 0.9× 25 822
Andrew Heath United States 9 616 1.4× 527 1.3× 132 1.2× 58 0.7× 63 0.8× 10 696
M Mathur India 13 119 0.3× 242 0.6× 63 0.6× 122 1.5× 75 0.9× 41 488
Miriam Ravins Israel 12 458 1.0× 381 1.0× 106 1.0× 134 1.6× 45 0.6× 23 598
Teruko Ohkura Japan 10 159 0.4× 180 0.5× 56 0.5× 81 1.0× 88 1.1× 15 348
Karen Jacques-Palaz United States 9 109 0.2× 333 0.8× 120 1.1× 159 1.9× 82 1.0× 11 478
Miranda van Luit‐Asbroek Netherlands 10 108 0.2× 362 0.9× 81 0.8× 236 2.8× 151 1.9× 10 481
Kikuyo Ogata Japan 13 193 0.4× 262 0.7× 60 0.6× 89 1.1× 101 1.2× 25 436
Josephine Weber-Heynemann Germany 7 491 1.1× 259 0.7× 170 1.6× 50 0.6× 50 0.6× 8 576
Prescilla Emy Nagao Brazil 16 271 0.6× 145 0.4× 200 1.9× 119 1.4× 128 1.6× 49 665

Countries citing papers authored by Joseph Jaffe

Since Specialization
Citations

This map shows the geographic impact of Joseph Jaffe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph Jaffe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph Jaffe more than expected).

Fields of papers citing papers by Joseph Jaffe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph Jaffe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph Jaffe. The network helps show where Joseph Jaffe may publish in the future.

Co-authorship network of co-authors of Joseph Jaffe

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph Jaffe. A scholar is included among the top collaborators of Joseph Jaffe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph Jaffe. Joseph Jaffe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Stein‐Zamir, Chen, Hanna Shoob, Nitza Abramson, et al.. (2023). Invasive Disease Due to Neisseria meningitidis: Surveillance and Trends in Israel Prior to and during the COVID-19 Pandemic. Microorganisms. 11(9). 2212–2212.
2.
Kopel, Eran, et al.. (2019). Surveillance of invasive meningococcal disease in the Tel Aviv District, Israel, 2007–2017. Vaccine. 37(42). 6186–6191. 1 indexed citations
3.
Amitai, Z., Analía V. Ezernitchi, Rivka Sheffer, et al.. (2018). Surveillance of listeriosis in the Tel Aviv District, Israel, 2010–2015. Epidemiology and Infection. 146(3). 283–290. 9 indexed citations
4.
Stein‐Zamir, Chen, Hanna Shoob, Nitza Abramson, et al.. (2018). Invasive meningococcal disease epidemiology and characterization of Neisseria meningitidis serogroups, sequence types, and clones; implication for use of meningococcal vaccines. Human Vaccines & Immunotherapeutics. 15(1). 242–248. 6 indexed citations
5.
Valinsky, Lea, et al.. (2015). A cluster of invasive meningococcal disease revealed by the characterization of a novel serogroup B meningococcal clone. Epidemiology and Infection. 144(1). 183–188. 5 indexed citations
6.
Block, Colin, Lea Valinsky, V. Temper, et al.. (2013). Déjà vu: Ralstonia mannitolilytica infection associated with a humidifying respiratory therapy device, Israel, June to July 2011. Eurosurveillance. 18(18). 20471–20471. 16 indexed citations
7.
Michael-Gayego, Ayelet, Mary Dan‐Goor, Joseph Jaffe, Carlos Hidalgo‐Grass, & Allon E. Moses. (2013). Characterization of sil in Invasive Group A and G Streptococci: Antibodies against Bacterial Pheromone Peptide SilCR Result in Severe Infection. Infection and Immunity. 81(11). 4121–4127. 12 indexed citations
8.
Gal‐Mor, Ohad, Lea Valinsky, Miriam Weinberger, et al.. (2010). Multidrug-ResistantSalmonella entericaSerovar Infantis, Israel. Emerging infectious diseases. 16(11). 1754–1757. 66 indexed citations
9.
Nir‐Paz, Ran, Colin Block, David Shasha, et al.. (2006). Macrolide, lincosamide and tetracycline susceptibility and emm characterisation of invasive Streptococcus pyogenes isolates in Israel. International Journal of Antimicrobial Agents. 28(4). 313–319. 12 indexed citations
10.
Hidalgo‐Grass, Carlos, Mary Dan‐Goor, Alexander Maly, et al.. (2004). Effect of a bacterial pheromone peptide on host chemokine degradation in group A streptococcal necrotising soft-tissue infections. The Lancet. 363(9410). 696–703. 123 indexed citations
11.
Cohen‐Poradosu, Ronit, Joseph Jaffe, Ran Nir‐Paz, et al.. (2004). Group G Streptococcal Bacteremia in Jerusalem. Emerging infectious diseases. 10(8). 1455–1460. 93 indexed citations
12.
Moses, Allon E., Carlos Hidalgo‐Grass, Mary Dan‐Goor, et al.. (2003). emm Typing of M Nontypeable Invasive Group A Streptococcal Isolates in Israel. Journal of Clinical Microbiology. 41(10). 4655–4659. 26 indexed citations
13.
Hidalgo‐Grass, Carlos, Miriam Ravins, Mary Dan‐Goor, et al.. (2002). A locus of group A streptococcus involved in invasive disease and DNA transfer. Molecular Microbiology. 46(1). 87–99. 87 indexed citations
14.
Ravins, Miriam, et al.. (2000). Characterization of a Mouse‐Passaged, Highly Encapsulated Variant of Group A Streptococcus in In Vitro and In Vivo Studies. The Journal of Infectious Diseases. 182(6). 1702–1711. 38 indexed citations
15.
Hanski, Emanuel, Joseph Jaffe, & Vered Ozeri. (1996). Proteins F1 And F2 of Streptococcus Pyogenes. Advances in experimental medicine and biology. 408. 141–150. 14 indexed citations
16.
Jaffe, Joseph, Shira Natanson‐Yaron, Michael G. Caparon, & Emanuel Hanski. (1996). Protein F2, a novel fibronectin‐binding protein from Streptococcus pyogenes, possesses two binding domains. Molecular Microbiology. 21(2). 373–384. 104 indexed citations
17.
Jaffe, Joseph, et al.. (1995). Cloning, sequencing and expression of two isoforms of the murine oct-1 transcription factor. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1261(2). 201–209. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026